Does Immunosuppression Prevent Pulmonary Arterial Hypertension in Systemic Sclerosis?

Does Immunosuppression Prevent Pulmonary Arterial Hypertension in Systemic Sclerosis?

Immunosuppression appears to reduce mortality among people with systemic sclerosis with pulmonary arterial hypertension but did not prevent the complication from occurring. Medscape Medical News

A patient who lives with pulmonary arterial hypertension (PAH), a disease that affects at least 4,000 people in Mexico, may take almost a year to reach his diagnosis, so it is urgent to improve the timely detection and knowledge of this disease, said one specialist. The entry Experts ask to improve the early detection of pulmonary arterial hypertension in Mexico was first published in Digital Process.

National Pulmonary Hypertension Day is observed on May 5th. It is a serious condition that affects 10% of older adults worldwide, to varying degrees, and can lead to severe complications such as right heart failure. "Prevention is the best strategy for taking care of our health. Identifying risk factors, attending medical checkups…" Source

On the occasion of World Pulmonary Hypertension Day, which is celebrated every May 5, the biopharmaceutical MSD reinforces its commitment to the patients and professionals who face this disease. Under the slogan “More air for your heartbeat”, and with the endorsement of the National Association of Pulmonary Hypertension and the Foundation Against Pulmonary Hypertension, the company seeks to give visibility to the challenges that still persist ar…